Company Details
| Sector | PHARMACEUTICALS | 
| Address | 35 - Dockyard Road West Wharf Karachi | 
| Auditor | Yousuf Adil, Chartered Accountants | 
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi | 
| Website | www.pk.gsk.com | 
| Fiscal Year | December | 
| Details | 
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement | 
|---|---|
| 27/04/2016 11:42:26 | FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2016 EPS = 2.19 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 697.188 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 914.134  | 
                                                    
| 30/03/2016 15:13:29 | EPS = 8.30 BOOK CLOSURE TO 27/04/2016 BOOK CLOSURE FROM 20/04/2016 ANNUAL GENERAL MEETING WILL BE HELD ON 27/04/2016 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,643.230 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 3,514.106 DIVIDEND = 40% FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2015  | 
                                                    
| 26/10/2015 15:46:40 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2015 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,699.852 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,974.852 EPS = 6.20  | 
                                                    
| 25/08/2015 15:07:25 | EPS = 2.61 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,210.640 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2015 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 832.889  | 
                                                    
| 29/04/2015 14:48:12 | EPS = 1.46 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 465.658 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 774.311 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2015  |